Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Ophthalmology

1594

A portion of ophthalmology that resists change unlike some other specialties is the consumer reluctance to undertake a procedure that may have side effects associated with vision like refractive laser correction. Any side effects concerning eyes/vision is typically avoided as much as possible especially if there are other options. Typically if the out-of pocket price for a life-enhancing procedure is within the budget of a consumer, the patient has a strong desire to get the procedure, and other factors are present that allow for it, the procedure is undertaken.
In laser correction there has been skepticism which has diminished as more patients undertake the procedure with good results. While new ideas, breakthrough technologies, cost efficiencies, increased productivity,and new markets are the keys to growth and competitiveness, most people [work force; consumers; academics; politicians] are more confident in familiar environments. They will resist change unless their job, livelihood, or lifestyles are threatened.

This phenomenon is partly responsible for the trend toward closing solo and small group practices to join vision care networks. Though this experience exists more in general medical practices and some pecialties, ophthalmologists also face the threat of practitioners [osteopathic physicians, doctors of optometry] replacing eye MDs—an intrusion on their medical training, skills, and specialty. However increasing healthcare costs, and economic changes sometimes force shifts in the typical work pattern of healthcare providers. One example is a change that has happened in states across the U.S. allowing optometrists to diagnose and treat glaucoma.

RSS Feeds

All reports in Ophthalmology

< prev 1  2  3  4  5  6  7  8  9  next >
Cataract Global Clinical Trials Review, H1, 2012
4/12/2012 | published by: GlobalData
... to the clinical trials on Cataract. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of ...  |  more...
$1,000.00
Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2012
4/12/2012 | published by: GlobalData
... scenario. This report provides elemental information and data relating to the clinical trials on Keratoconjunctivitis sicca (Dry Eye). It includes an overview of the trial numbers and their recruitment status as per the site of ...  |  more...
$1,000.00
3rd World Congress on Controversies in Ophthalmology 2012 - Post-Conference Review and Analysis
3/27/2012 | published by: GlobalData
... Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new disease management techniques. The annual symposium of the 3rd World Congress on Controversies in Ophthalmology ...  |  more...
$1,000.00
Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... provides information on the therapeutic development for Keratoconjunctivitis sicca (Dry Eye), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Keratoconjunctivitis ...  |  more...
$500.00
Ocular Hypertension – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Ocular Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ocular Hypertension. 'Ocular Hypertension - Pipeline Review, H1 2012' ...  |  more...
$500.00
Ophthalmic Drugs: World Market Prospects 2012-2022
3/16/2012 | published by: Visiongain
... study investigates prescription drugs treating human eye diseases. It lets you assess forecasted sales trends at world market, therapeutic submarket, product and national level to 2022. How will 20 leading ophthalmic drugs - including Lucentis, ...  |  more...
$2,642.00
Glaucoma – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glaucoma. 'Glaucoma - Pipeline Review, H1 2012' is built using data and information ...  |  more...
$500.00
Macular Degeneration – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... for Macular Degeneration, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Macular Degeneration. 'Macular Degeneration - Pipeline Review, H1 2012' ...  |  more...
$500.00
Age Related Macular Degeneration Global Clinical Trials Review, H1, 2012
2/20/2012 | published by: GlobalData
... scenario. This report provides elemental information and data relating to the clinical trials on Age Related Macular Degeneration. It includes an overview of the trial numbers and their recruitment status as per the site of ...  |  more...
$1,000.00
Eye Care In Israel
2/15/2012 | published by: Euromonitor International
... standard eye care that treats dry eyes after the procedure. Euromonitor International's Eye Care in Israel report offers a comprehensive guide to the size and shape of the market at a national level. It provides ...  |  more...
$900.00
Optometry and Optical Dispensing in Australia - Industry Market Research Report
2/9/2012 | published by: IBISWorld
... It also includes establishments with optical dispensers, mainly engaged in dispensing spectacles or contact lenses, and registered orthoptists mainly engaged in diagnosing and treating ocular muscle disorders. This report covers the scope, size, disposition and ...  |  more...
$1,000.00
Optometrists in the US - Industry Market Research Report
2/7/2012 | published by: IBISWorld
... a huge boost for this industry, as those who have delayed eye examinations may begin to make appointments for eye examinations when economic conditions improve. At the same time, the aging baby boomers will provide ...  |  more...
$910.00
Analysis of the United States Glaucoma Pharmaceuticals Market
1/27/2012 | published by: Frost & Sullivan
... development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by classes of drug: prostaglandins, beta-blockers, alpha-adrenerigic agonists, carbonic anhydrase inhibitors, and fixed-dose combinations.  |  more...
$6,000.00
A Comprehensive Study Of The UK Opticians Market In 2010, Rating & Valuing Each Of The 875 Companies That Operate In Today's Market
1/3/2012 | published by: Plimsoll Publishing Ltd.
... Identify under performing companies for acquisition Seek out successful companies to partner or do business with Understand the key movers and shakers in today’s market Each company receives the following unique features: A 5 year ...  |  more...
$350.00
Ophthalmic Lasers
1/1/2012 | published by: Global Industry Analysts
... the global ophthalmic lasers industry, identifies major short to medium term market challenges, and growth drivers. Regional markets elaborated upon include US, Canada, Japan, Europe (France, Germany, Italy, United Kingdom, and Rest of Europe), Asia-Pacific, ...  |  more...
$1,450.00
2011 Pharmaceuticals Research Review
1/1/2012 | published by: BCC Research
... at a compound annual growth rate (CAGR) of 12.5% for the five year period of 2011 to 2016. The overall emerging markets for therapeutic drugs totaled $131.4 billion in 2009. These regions include Latin America, ...  |  more...
$850.00
Special Report: Thought-Leader Opinion on the Current and Future Landscape of the Age-Related Macular Degeneration Market
12/7/2011 | published by: Decision Resources
... is the leading cause of irreparable vision loss in the United States. Interviewed U.S. experts indicate substantial unmet needs in current AMD treatment. With only a few approved therapies, this market presents a big opportunity ...  |  more...
$9,200.00
American Academy of Ophthalmology (AAO) 2011 Annual Meeting - Review and Analysis
11/30/2011 | published by: GlobalData
... companies with their exhibited products at the AAO 2011 annual meeting. The report provides the highlights of the meeting, presentations, market dynamics and key participants with description on their exhibited products. This report is built ...  |  more...
$1,000.00
Cataract - Pipeline Review, H2 2011
11/28/2011 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cataract. 'Cataract - Pipeline Review, H2 2011' is built using data and information ...  |  more...
$500.00
Eye Care in Saudi Arabia
11/9/2011 | published by: Euromonitor International
... appearance, consumers increasingly shied away from wearing glasses, with many opting for contact lenses and others opting for surgery. This resulted in growing use for eye care. Euromonitor International's Eye Care in Saudi Arabia report ...  |  more...
$900.00
China Ophthalmology Prescription Drug Sales Data 2006-2010
11/1/2011 | published by: Draco Healthcare Consulting LLC
... and drug purchasing data from extensive hospital coverage in 16 major cities and more than 300 hospitals. Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, ...  |  more...
$8,000.00
Allergic Conjunctivitis - Pipeline Review, H2 2011
10/26/2011 | published by: Global Markets Direct
... for Allergic Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Allergic Conjunctivitis. 'Allergic Conjunctivitis - Pipeline Review, H2 2011' ...  |  more...
$500.00
Eye Care In The Netherlands
10/25/2011 | published by: Euromonitor International
... cited is that consumers do not usually buy such products on their own, seeking medical recommendation based on safety grounds. Euromonitor International's Eye Care in Netherlands report offers a comprehensive guide to the size and ...  |  more...
$900.00
Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2011
10/22/2011 | published by: GlobalData
... scenario. This report provides elemental information and data relating to the clinical trials on Keratoconjunctivitis sicca (Dry Eye). It includes an overview of the trial numbers and their recruitment status as per the site of ...  |  more...
$1,000.00
Glaucoma Global Clinical Trials Review, H2, 2011
10/22/2011 | published by: GlobalData
... to the clinical trials on Glaucoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of ...  |  more...
$1,000.00
< prev 1  2  3  4  5  6  7  8  9  next >